AI MARKET SCANNING

Syndax Pharmaceuticals Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +0.79%
MAX GAP RECORD +19.56%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $SNDX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE)
-9.28%
Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE)
-2.80%
Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE)
-3.24%
Nov 03, 2025 Earnings Release 2025-11-03 (AFTER CLOSE)
-1.16%
Aug 04, 2025 Earnings Release 2025-08-04 (AFTER CLOSE)
+19.56%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+2.54%
Mar 03, 2025 Earnings Release 2025-03-03 (BEFORE OPEN)
+2.62%
Nov 05, 2024 Earnings Release 2024-11-05 (AFTER CLOSE)
+9.70%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.3%
Bullish Gaps (5)
Bearish Gaps (7)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $SNDX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗